Delivery Order SPE2DB20D7061-SPE2DB25FSMR1

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,091.35 firm fixed-price delivery order is for the supply of Synthroid 100 mcg tablets in 1,000-count containers. The contract has an ultimate completion date of April 11, 2025 and is not set aside. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $22,011.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,566,384,098 units of Synthroid 137 MCG Tablet 1000s, with a completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award is for $32,236.00 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp. The award covers the delivery of Synthroid 137 MCG tablets in quantities of 1,000. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 25, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that is a key vendor for federal...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Synthroid 137 mcg tablets in 1,000 count packages, with a total ceiling value of $14,870.04. This is a delivery order contract with a firm fixed price pricing type, with a period of performance through March 18, 2025. AmerisourceBergen holds a significant...
This federal contract award, valued at $2,078.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Synthroid 88 MCG tablets in quantities of 1,000. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,503.62 firm fixed-price delivery order is for the supply of Synthroid 137 mcg tablets in quantities of 1,000. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $1,405.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Synthroid 125 MCG Tablets in quantities of 1,000. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 24, 2025. No set-aside designation was used for this award. Additionally, AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,958.96 firm fixed-price delivery order is for 4,567,034,802 units of Synthroid 88 MCG tablets, a medication used to treat hypothyroidism. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $5,443.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,014,211 tablets of Synthroid 137 MCG, a medication used to treat hypothyroidism. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,180.65 contract is for the delivery of Synthroid 137 MCG tablets to the Conshohocken, Pennsylvania location. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 and awarded solely to Amerisourcebergen Drug Corp, which serves as the...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB25FSMR1
    Delivery Order

This federal contract award, valued at $7,421.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Synthroid 137 MCG Tablets in 1,000-count containers. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 1:29 AM